Moderna Biopharma Canada Corporation
Registration:
1
of
1
(2024-05-28
to
present)
Details Regarding the Identified Subject Matter
Subject matters
|
Details
|
Categories
|
Economic Development, Government Procurement, Health, Industry
|
To discuss the successful execution of existing and future vaccine procurements and the successful launch of the Moderna Laval facility. Also identifying opportunities to increase biomanufacturing capabilities in Canada.
|
Government Contract Pursued
|